Clearmind Medicine (CMND) Accumulated Expenses (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Accumulated Expenses of $713629.0 for Q2 2026, up 50.08% year-over-year from $475490.0 in Q2 2025, and down 21.81% quarter-over-quarter from $912718.0 in Q1 2026.
Clearmind Medicine (CMND) Accumulated Expenses (2021 - 2026) Analysis & Trends
Clearmind Medicine's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $713629.0 for Q2 2026.
- In Q2 2026, Accumulated Expenses rose 50.08% year-over-year to $713629.0; the TTM figure through Apr 2026 stood at $713629.0 (up 50.08% YoY), while the FY2025 annual figure was $682163.0, up 29.67% from the prior year.
- Accumulated Expenses for Q2 2026 stood at $713629.0, down from $912718.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $1.4 million in Q4 2022, with the low at $276744.0 in Q3 2024.
- The 5-year median for Accumulated Expenses is $646919.0 (2025), against an average of $649966.8.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses surged 417.27% in 2022, then tumbled 57.02% in 2023.
- Clearmind Medicine's Accumulated Expenses stood at $1.4 million in 2022, then sank by 57.02% to $617004.0 in 2023, then fell by 14.74% to $526056.0 in 2024, then gained by 29.67% to $682163.0 in 2025, then increased by 4.61% to $713629.0 in 2026.
- Business Quant data shows CMND's Accumulated Expenses at $713629.0 in Q2 2026, $912718.0 in Q1 2026, and $682163.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 713,629.00 |
| Jan 31, 2026 | 912,718.00 |
| Oct 31, 2025 | 682,163.00 |
| Jul 31, 2025 | 646,919.00 |
| Apr 30, 2025 | 475,490.00 |
| Jan 31, 2025 | 654,187.00 |
| Oct 31, 2024 | 526,056.00 |
| Jul 31, 2024 | 276,744.00 |
| Apr 30, 2024 | 421,156.00 |
| Jan 31, 2024 | 608,520.00 |
| Oct 31, 2023 | 617,004.00 |
| Jul 31, 2023 | 306,011.00 |
| Apr 30, 2023 | 805,453.00 |
| Jan 31, 2023 | 667,901.47 |
| Oct 31, 2022 | 1.44 Mn |
| Oct 31, 2021 | 277,524.26 |